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Purpose: This paper was mainly aimed to investigate drug resistance of the various urinary tract 
infection (UTI) pathogens from patients of different gender and age groups of Pakistanis. 
Method: For these purposes, urine samples of 109 patients were analyzed. Samples were screened on 
CLED agar. Antimicrobial susceptibility testing was performed by Kirby Bauer's disc diffusion method. 
Isolated colonies were processed for biochemical characterization and antibiotic sensitivity to ampicillin, 
amikacin, augmentin, ceftazidime, ceftriaxone, cefuroxime, cotrimoxazole, ciprofloxin, imipenem, 
meropenem, tazocine, trimethoprim, gentamicin and nitrofuratoin. 
Result: E.Coli was found to be the most frequent causative agent of UTIs (66%)  followed by 
Enterococci (8.3%), Candida spp. and Pseodomonas spp. (7.3% each), Klebsiella spp. (5.5%) and 
Enterobacter spp. (2.7%).  Proteus. and Morgenella species were found in less than 1% of the cases. 
E.coli showed variable antimicrobial resistance to different antibiotics as  92%, 86%, 80%, 62%, 47%, 
20% and 4% of the isolates were found to be resistant to ampicillin, cotrimoxazole, ciprofloxin, 
gentamicin, nitrofuratoin and amikacin, respectively. 
Conclusion: The most effective in vitro agents were found to be amikacin followed by gentamicin 
(among the parenterals), and ciprofloxin among the orally administratered ones. A higher prevalence of 





 in both genders. 
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INTRODUCTION 
With the constantly shifting trends in drug 
resistance, antibiotic options, and 
pharmacoeconomic considerations, urinary 
tract infections (UTIs) continue to be one of 
the most frequently diagnosed cases, having 
an estimated figure of 150 million per annum 
worldwide. In fact, UTIs are the leading cause 
of gram-negative bacteremia in patients of all 
ages and are associated with a high risk of 
morbidity and mortality, especially in the 
elderly, and account for significant health care 
costs.
1, 2 
Warren et al 
3
 have reported that in 
the United States, urinary tract
 
infections 
result in approximately 8 million physician 
visits
 
per year.  
In spite of the availability and use of the 
antimicrobial drugs, UTIs caused by bacteria 
have been showing increasing trends in 
recent years. Much of the increase has been 
related to emerging antibiotic resistance in 
urinary tract pathogens.
4
 The common 
uropathogens identified in adult patients with 
UTIs include enteric gram-negative bacteria, 
with E. coli being the most common. The 
remainders of infections are caused by 
coagulase-negative Staphylococcus 
saprophyticus (10-20%), while Proteus 
mirabilis, Klebsiella, and Enterococcus 
account for less than 5%
1,5,6
. Other aerobic 
gram-negative bacteria of the 
Enterobacteriacea family include Citrobacter, 
Enterobacter, Serratia, and Salmonella
3,7
. 
The high incidence of UTIs in the general 
population, the potential for complications, 
especially in high-risk subgroups and the 
associated costs of treatments emphasize the 
importance of appropriate antibiotic therapy. 
Microbial resistance to nearly all classes of 
antimicrobials continues to rise despite 




The situation is more adverse where 
indiscriminate use of antibiotics is rampant. In 
Pakistan, general practitioners, at large, 
recommend antibiotics without isolation and 
sensitivity test for pathogens. Poverty and 
illiteracy further strengthen the indiscriminate 
use of antibiotics including the low/high dose 
intake, incomplete course and a general trend 
of using left over drugs. Such practices may 
result an increase in resistant pathogens. The 
present report describes some data in this 
regard. For this purpose one hundred and 
nine positive urine samples received at 
Shaukat Khanum cancer hospital, Lahore 
were employed to isolate and characterize the 
pathogens for UTIs and to make comparison 
of antibiotics sensitivity/ resistance patterns. 
These data provide baseline information for 





This study focuses on the antibiotic 
susceptibility patterns and frequency of 
uropathogens in different gender and age 
groups. 109 positive human urine samples 
obtained from different collection points and 
hospitalized patients at Shaukat Khanum 
cancer hospital and research center, Lahore 
were used for this purpose. These samples 
were processed to monitor urinary tract 
infection and antibiotics sensitivity patterns of 
pathogenic bacteria. The data were 
categorized viz gender and age. This study 
was approved from the University of the 
Punjab. Lahore. 
Study Protocols  
The specimens were collected for about three 
months between February 2004 to April 
2004.The specimens which grew positive 
were selected for further analysis. 
The specimens which grew more then one 
type of colonies were excluded from this 
study. The specimens whose age or sex 
record were not available were also rejected. 
A bacterial colony count of 10,000 cfu/ml  and 
100,000 cfu/ml of urine for patients 0-16 years 
and above 16 years respectively, was 
selected as criterion for inclusive in the study. 
It is identical to that used to diagnose UTI in a 
number of previous studies
4,8. 
Lactobacilli and 
coagulase-negative Staphylococci were 
considered as contaminants and were also 
excluded from the study. 
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The urine samples were inoculated on 
cysteine lactose electrolyte deficient agar 
(CLED). All Gram negative rods and 
enterococci were identified by using 
conventional biochemicals plus API 20E 
(Biomeurex) and Oxoid Streptococcal 
grouping kits, respectively. Antibiotic 
sensitivity testing of all isolates was performed 
on muller hinton agar plates by Kerby-Baure 
disk diffusion technique with guidelines 
established by National Committee for Clinical 
Laboratory Standards ( NCCLS )
13
 Oral 
antibiotics for which uropathogens were tested 
include; ampicillin, trimethoprime, ciprofloxin,  
nitrofuratoin, augmentin, and 
cotrimoxazole.Parental antibiotics include; 
gentamicin, amikacin, imipenem, meropenem, 
, ceftazidime, ceftriaxone, cefuroxime, and 
Tazocin.  
Data Analysis 
Data were categorized viz age and sex. The 
patients were divided into age groups as 0+ 
(0-9 years), 10+ (10-19 years), 20+ (20-29 
years), 30+ (30-39 years), 40+ (40-49 years), 
50+ (50-59 years), 60+ (60-69 years), 70+ 




When the data were classified into different 
age and gender groups, it appeared that the 
cases of urinary tract infections (UTIs) were 
more in boys than girls of less than ten years 
of age. For the age group 20+ the females 
showed more than double the % of UTIs 
cases in males. For the next age group (30+) 
the situation appeared inverse to the 
preceding age group. Then for the age groups 
40+ and 60+ females had 6.64% and 6.73% 
higher prevalence of the infection respectively 
than the corresponding male groups. However 
for age group 50+ gender wise difference was 
not prominent. For 70+ age group the cases 
for males appeared double than the females 
(Table 1). 
Among the uropathogens E.coli was the most 
frequent in both sexes with 44.45 % and 
78.1% frequencies in male and female 
patients, respectively. Enterococci caused two 
folds (9.6 %) UTIs in females than the males 
(5.55%). Candida, Pseudomonas and 
Klebsiella were isolated from 13.89 %, 13.89 
% and 11.11 % of the males, respectively. For 
females the corresponding figures were 4.1 
%, 4.1% and 2.74%, respectively. The 
uropathogens, nterobacter (8.33 %) and 
Morganella (2.78 %) appeared only in males. 
UTI cases caused by Proteus appeared 1.36 
% in females only (Table 2).  
When sensitivity to different antibiotics was 
compared, imipenen, meropenum and tazocin 
were found effective against the bacterial 
isolates from both sexes. It is surprising that 
all the antibiotics, except amikacin, showed 
more resistance in male patients than 
females. Nitrofuratoin showed about two folds 
resistance in males than females, while 
Trimethoprim, cotrimoxazole and ceftazidime 
showed 11% more resistance in males than 
females. Ceftriaxone, ciprofloxin, ampicillin 
and augmentin showed 13%, 14%, 16% and 
20 % more resistance in males as compared 
to females, respectively (Table 3). 
E.coli did not show resistance to imipenen, 
meropenum and tazocin in all age groups of 
males. On the other hand the bacteria 
manifested almost complete resistance to 
ampicillin, trimethoprim and cotrimoxazole in 
all the age groups. The isolates from below 40 
years male patients and age groups 50+ and 
70+ showed almost complete resistance to 
ciprofloxin, while it was effective in half of 
male patients in age groups 40+ and 60 +. 
Amikacin experienced little resistance in age 
groups 20+(16.66 %), 40+(8.33%), 50+(10%) 
and 70+(16.66%), while for other age groups 
it was completely effective.  Different trends in 
resistance for the different age groups are 
shown in this study.  
Bacterial isolates from females showed 
relatively less resistance than males. 
Imipenem, tazocin, meropenum and amikacin 
were found effective in most of the age 
groups, while these drugs showed 16.66% 
resistance in age group 20+. Nitrofurantoin 
showed 33% resistance in age groups 0+, 20+ 
and 30+ and was found almost sensitive in all 
other age` groups. Ampicillin faced almost 
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complete resistance in all age groups except 
0+, 20, + and 70+ for which 67% resistance 
was recorded. Augmentin showed variation in 
resistance from 25% to 70% in different age 
groups and was found to be sensitive in age 
groups 10+ and 20+. Ceftriaxone showed 
60% resistance in age group 60+. ceftriaxone 
was sensitive in age group 10+, while it 
showed variable resistance among other age 
groups. Ciproflaxin, cotrimoxazole and 
trimethoprim showed variable resistance 
patterns in all age groups except 40+ in which 
Table 1: Prevalence of UTIs in males and females of different age groups 
Age groups (Years) Male (%) Female (%) 
0+ 5
a
 13.88 9 12.33 
10+ 2 5.55 5 6.85 
20+ 2 5.55 10 13.69 
30+ 5 13.88 4 5.48 
40+ 4 11.17 13 17.81 
50+ 7 19.44 14 19.19 
60+ 3 8.33 11 15.06 
70+ 5 13.88 6 8.22 
80+ 1 2.77 0 0 
90+ 2 5.55 1 1.37 
Total 36 100 73 100 
 
a Number of cases representing a given age group out of total 109 cases. 
 
Table 2: Prevalence of different UTI pathogens among male and female patients 
 
Pathogens                    Male                            Female                          Total no. of isolates 
Candida 5 (13.89)ª 3 (4.1) 8 (7.35) 
E.coli 16 (44.45) 57 (78.1) 73 (66.97) 
Enterobacter 3  (8.33) 0 (0) 3 (2.75) 
Enterococci 2 (5.55) 7 (9.6) 9 (8.26) 
Klebsiella 4 (11.11) 2 (2.74) 6 (5.5) 
Morganella 1 (2.78) 0 (0) 1 (0.91) 
Proteus 0 (0) 1 (1.36) 1 (0.91) 
Pseudomonas 5 (13.89) 3 (4.1) 8 (7.35) 
 




 Values in parenthesis indicate the percentage of the isolate for a given gender. 
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these antibiotics were effective among half the 
female patients. (see Table 4). In general, 
E.coli isolates in this study showed varying 
patterns of antimicrobial resistance to different 
antibiotics viz ampicillin about (92%), 
trimethoprim (86%) cotrimoxazole (80%), 
ciprofloxin (62%), gentamicin, (49%)  
nitrofuratoin (20%) and amikacin (4%). 
Enterococci, the only gram positive isolate, 
was found to be susceptible to ampicillin, 
imipenem, penicillin, tazocin and vancomycin. 
The Enterococci isolates showed resistance to 




The most frequent causative agent of UTIs in 
this study was found to be E.Coli (66.97%) 
followed by Enterococci (8.26%), Candida 
spp. and Pseodomonas spp.(7.34% 
each),Klebsiella spp.(5.50%), Enterobacter 
spp. (2.75%),Proteus spp. and Morgenella 
spp.(0.91% each). In two other studies in 
Pakistan, Khan
6 
reported a uropathogens 
prevalence of  45.6% for E. coli. This was 
followed by Candida spp. (10.5%), 
Enterococcus spp. (10.2%) while Farooqy
14
 
revealed a prevalence of 42% for E. coli, 16% 
Pseudomonas aeruginosa, 11% Klebsiella 
aerogenes, 5.0% ,Enterobacter spp., 13% 
Proteus spp., 4.0% Serratia liquifaciens, 
1.0%,Acinetobacter spp., 3.0% Citrobacter 
spp., 4.0% Enterococci and 0.5% 
Staphylococcus aureus. Prevalence of 
different pathogens is dependent on several 
population attributes, sample size and 
hygienic conditions of the patients. Therefore, 
a stable pattern in this regard cannot be 
predicted. This is why data vary when different 
studies are compared. For example, Hsueh et 
al
15
 have reported that   the most frequent 
isolates from UTIs at a university hospital in 
Taiwan during the period 1993 -  1998 were 
Candida spp. (23.6%), E.Col i(18.6%) and 
P.aeruginosa (11.0%). However, in 1999, 
E.Coli (18.4%) replaced Candida spp. (14.3%) 
as the top ranking pathogen causing UTIs. 
The consistently high prevalence of resistance 
to cotrimoxazole and an increasing pattern
 
of 
resistance to ciprofloxacin require ongoing 
surveillance
 
to identify further changes among 




 The in vitro 
activities of nitrofuratoin and the other 
antibiotics with even lesser resistance found in 
the present study suggest that they
 
would 
provide adequate alternative therapy in 
locations where
 
the uropathogens E.coli had 
developed multi drugs resistance
17
Planning to 
reduce resistance is very important, as 
organisms resistant to one antimicrobial agent 
are likely to become resistant to others. 
Researchers have found that bacteria isolated 
from UTIs have resistance to common drugs 
such as ampicillin and sulphonamides in over 
one-third of cases. These drugs have been on 
the market for several decades
16
 
In the present study when the data were 
visualized in different age groups for both 
genders, it appeared that in the case of males, 
E.coli isolates were susceptible to nitrofuratoin 
in age groups 0+, 50+ and 70+, while in age 
groups 20+, 30+ and 60+ hundred percent 
resistance was recorded. E.Coli In females, 
showed no resistance to nitrofuratoin in age 
groups 10+, 50+ and 70+, while it showed 
33% resistance in age groups 0+, 20+ and 
30+. E.Coli  isolates from age groups 50+ and 
70+  both in males and females were found to 
be 100% susceptible to the 
nitrofuration.(Table 4) Such varying pattern of 
resistance also appeared in different age and 
gender groups to other antibiotics in this 
study. These findings are difficult to explain. 
McLoughlin and Joseph
18
 have indicated that 
prevalence of resistant organisms vary by 
geography, patient age, and hospitalization 
status. The present analysis indicates the 
more likelihood of selective development of 
resistance to some antibiotics in certain age 
groups may have link(s) with physiological 
differences amongst the groups. However, 
such data appear beneficial to physician for 
empirical prescriptions of different antibiotics 
taking into account many age groups. The 
activity of the antibiotics investigated in this 
study against E.coli in female patients are as 
follows, in decreasing order: imipenem = 
meropenum > tazocin > amikacin > 
nitrofurantoin > ceftazidime >  ceftriaxone > 
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gentamicin = augmentin > cefuroxime > 
ciprofloxin > cotrimoxazole = trimethoprim> 
ampicillin. For isolates from male patients, as 
the order is: imipenem = meropenum = 
Table3: Prevalence (%) of antibiotics resistance in  E.coli isolated from males and females 
Antibiotics Males Females  Total 
Ampicillin 100                    84.21 92 
Augmentin 68.75 47.36 58 
Ceftazidime 43.75 26.31 35 
Ceftriaxone 56.25 43.85 50 
Cefuroxime 68.75 49.12 60 
Imipenem 0 1.75 1.75 
Meropenum 0 1.75 1.75 
Tazocin 0 3.5 3.5 
Amikacin 0 7.01 7 
Gentamicin 50 47.36 49 
Ciproflaxin 68.75 54.38 62 
Cotrimoxazole 81.25 78.94 80 
Trimethoprim 93.75 78.94 86 
Nitrofuratoin 25 14 20 
 
Table 4: Prevalence (%) of E.coli resistance to different antibiotics isolated from males of and  
females of different age groups      
 
      Antibiotics     Age in years  

































































































































































































































Values within parentheses indicate female patients; NSR = no sample received 
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tazocin= amikacin > nitrofuratoin > 
ceftazidime > gentamicin > ceftriaxone > 
augmentin = Cefuroxime= ciprofloxin > 
cotrimoxazole > trimethoprim > ampicillin.
 
Similar orders can be worked out for isolates 
with respect to different age groups. These 
resistance and susceptibility patterns should 
be considered in order to improve empirical 
antibiotic therapy in UTI cases. 
 
CONCLUSION 
The organisms showed resistance to older 
urinary antimicrobial agents such as ampicillin 
and cotrimoxazole; this indicates that 
increased consumption of a particular 
antibiotic can be a pathway to its resistance. 
Higher prevalence of UTIs was observed in 
female population. The prevalence of UTIs 
was highest for age group 50+ followed by 0+ 
in both genders. E.coli showed no resistance 
to nitrofuratoin in age groups 50+ and 70 + for 
both genders.  
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